{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-03T13:57:55.569390+00:00","company":{"ticker":"MRK","cik":310158,"company_name":"Merck & Co., Inc."},"pagination":{"limit":100,"returned":4,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"earnings_release","fact_key":"6872b0c09b01c753aca4761532475d3c466960ef","cik":310158,"ticker":"MRK","company_name":"Merck & Co., Inc.","filed_at":"2026-04-30T23:59:59+00:00","payload":{"eps_text":"(1.72)","guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":"(4,240)","period_text":"first quarter of 2026","report_date":"2026-04-30","result_type":"reported_results","revenue_text":"$16,286"},"claim":"Merck & Co., Inc. reported first quarter of 2026 results: revenue $16,286, net income (4,240), EPS (1.72). Guidance raised.","evidence_excerpt":"First Quarter $ in millions, except EPS amounts 2026 2025 Change Change Ex- Exchange Sales $ 16,286 $ 15,529 5 % 3 % GAAP net (loss) income 2 (4,240 ) 5,079 N/M N/M Non-GAAP net (loss) income that excludes certain items 2,3* (3,156 ) 5,611 N/M N/M GAAP EPS (1.72 ) 2.01 N/M N/M","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-26-052081","anchor_url":"https://secwatch.observer/filing/0001104659-26-052081#claim-6872b0c09b01c753aca4761532475d3c466960ef","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/310158/000110465926052081/0001104659-26-052081-index.htm"},{"fact_type":"restructuring_charge","fact_key":"1a4228ae83f9f0f174cc51a2befdf1e184f48ba1","cik":310158,"ticker":"MRK","company_name":"Merck & Co., Inc.","filed_at":"2025-07-29T23:59:59+00:00","payload":{"affected_area":"sales and administrative organizations, research and development, global real estate footprint, manufacturing network","charge_text":"approximately $3.0 billion","effective_date":"2025-07-25","event_type":"restructuring","headcount_text":null,"item_codes_triggered":["2.05"]},"claim":"Merck & Co., Inc. announced a restructuring with charges of approximately $3.0 billion affecting sales and administrative organizations, research and development, global real estate footprint, manufacturing network.","evidence_excerpt":"expected to be substantially completed by the end of 2029. The cumulative pretax costs to be incurred by the Company to implement\nthe program are estimated to be approximately $3.0 billion, of which approximately 60% will be cash, relating primarily to employee separation\nexpense and contractual termination costs. The remainder of the costs will be non-cash,","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-25-071380","anchor_url":"https://secwatch.observer/filing/0001104659-25-071380#claim-1a4228ae83f9f0f174cc51a2befdf1e184f48ba1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/310158/000110465925071380/0001104659-25-071380-index.htm"},{"fact_type":"executive_change","fact_key":"0a00926e5d","cik":310158,"ticker":"MRK","company_name":"Merck & Co., Inc.","filed_at":"2024-11-22T23:59:59+00:00","payload":{"action":"elected","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-01-01","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Surendralal L. “Lal” Karsanbhai was elected as Director at Merck & Co., Inc..","evidence_excerpt":"announcing the election of Surendralal L. “Lal” Karsanbhai to the Company’s Board of Directors (the “Board”), effective January 1, 2025.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-122027","anchor_url":"https://secwatch.observer/filing/0001104659-24-122027#claim-0a00926e5d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/310158/000110465924122027/0001104659-24-122027-index.htm"},{"fact_type":"earnings_release","fact_key":"c723769b7ea088214c6fa4e86a04ba8de6403adb","cik":310158,"ticker":"MRK","company_name":"Merck & Co., Inc.","filed_at":"2024-04-25T23:59:59+00:00","payload":{"eps_text":"GAAP EPS 1.87; Non-GAAP EPS that excludes certain items 2* 2.07","guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":"4,762","period_text":"first quarter of 2024","report_date":"2024-04-25","result_type":"reported_results","revenue_text":"$15,775"},"claim":"Merck & Co., Inc. reported first quarter of 2024 results: revenue $15,775, net income 4,762, EPS GAAP EPS 1.87; Non-GAAP EPS that excludes certain items 2* 2.07. Guidance raised.","evidence_excerpt":"Financial Summary First Quarter $ in millions, except EPS amounts 2024 2023 Change Change Ex- Exchange Sales $ 15,775 $ 14,487 9 % 12 % GAAP net income 1 4,762 2,821 69 % 76 % Non-GAAP net income that excludes certain items 1,2* 5,279 3,564 48 % 54 % GAAP EPS 1.87 1.11 68 % 76 % Non-GAAP EPS that excludes certain items 2* 2.07 1.40 48 % 54 %","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-051517","anchor_url":"https://secwatch.observer/filing/0001104659-24-051517#claim-c723769b7ea088214c6fa4e86a04ba8de6403adb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/310158/000110465924051517/0001104659-24-051517-index.htm"}]}